NeuroPace, Inc. (NPCE) Social Stream



NeuroPace, Inc. (NPCE): $4.91

0.01 (+0.20%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NeuroPace Inc (NPCE) Price Targets From Analysts

Use the tables below to see what analysts covering NeuroPace Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-28 5 $30 $24 $26.4 $8.48 211.32%
2021-11-11 5 $30 $17 $25 $8.48 194.81%
2022-01-07 5 $30 $12 $23.4 $8.48 175.94%
2022-02-01 5 $26 $11 $17.6 $8.48 107.55%
2022-03-17 5 $26 $9 $14.6 $8.48 72.17%

The Trend in the Analyst Price Target


NPCE's average price target has moved down $11.8 over the prior 140 days.

NPCE reports an average of 48.88% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-24 3 30 26 28.0 23.54 18.95%
2021-08-01 3 30 26 28.0 21.30 31.46%
2021-08-05 3 30 26 28.0 23.14 21%
2021-09-11 4 30 26 27.5 20.46 34.41%
2022-02-01 5 26 11 17.6 8.42 109.03%

NPCE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.94 3 0 1 0 0 5

The Trend in the Broker Recommendations


Over the past 120 days, NPCE's average broker recommendation rating worsened by 1.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • NeuroPace Inc's upside potential (average analyst target price relative to current price) is higher than 499.33% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, NeuroPace Inc's variance in analysts' estimates is lower than -333.47% of them.
  • To contextualize these metrics, consider that out of all US stocks, NeuroPace Inc's average analyst price target is higher than 149.75% of them.
  • In the context of stocks in the small market cap category, NeuroPace Inc's number of analysts covering the stock is greater than 383.16% of them.

In the Medical Equipment industry, NMRD, MDXG, and LQDA are the three stocks most similar to NeuroPace Inc regarding the price target and analyst recommendation information presented here.

Is NPCE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4695 seconds.